Herpes Zoster Drug Market Poised for Substantial Growth Amid Rising Shingles Cases and Advancements in Antiviral Therapies
The Herpes Zoster Drug Market is witnessing significant growth, driven by the increasing prevalence of shingles infections worldwide. With an aging global population and growing awareness of herpes zoster-related complications, the demand for effective antiviral drugs and vaccines has surged. According to DataIntelo, the global herpes zoster drug market was valued at USD 3.8 billion in 2024 and...
0 Comments 0 Shares